Stay updated on Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Sign up to get notified when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.

Latest updates to the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision history shows Revision: v3.5.4 replacing Revision: v3.5.3, indicating a small metadata update to the entry. This does not reflect substantive changes to study details or content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s software/display footer revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now lists Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no visible changes to study details or page layout.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check112 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous v3.4.1. This appears to be a minor metadata update with no substantive changes to the study content or displayed information.SummaryDifference0.1%

Stay in the know with updates to Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad-p53+Xeloda/Anti-PD-1 Safety/Efficacy in Liver Metastases Clinical Trial page.